Skip to Content

Research

AURORA

Research

Research

Clinicaltrial.gov identifier:
NCT02102165
Status:
Recruiting
Scenario:
Locally Advanced or Metastatic Study, no CT no PAS (Post-Approval Studies), without drug
Tumour subtype:
Others
Drug/Intervention:
Biopsy

Aiming to understand the molecular aberrations in metastatic breast cancer

In order to exploit the potential of tumor molecular characterization, the Breast International Group (BIG) has set up AURORA – a large, multinational, collaborative metastatic BC (MBC) molecular screening program.

Collaborators

Breast European Adjuvant Studies Team
Frontier Science & Technology Research Foundation, Inc.

Principal investigators

Piccart Martine, MD, PhD

Breast International Group (BIG) chair

X
Utilizamos cookies propias y de terceros para mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Puede cambiar la configuración u obtener más información aquí.